ROKIT Healthcare Inc. (KOSDAQ:376900)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,350
+530 (3.58%)
At close: Aug 13, 2025, 3:30 PM KST
-8.96%
Market Cap 238.93B
Revenue (ttm) 13.51B
Net Income (ttm) -7.39B
Shares Out 15.41M
EPS (ttm) -932.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 232,106
Average Volume 321,591
Open 15,000
Previous Close 14,820
Day's Range 14,700 - 15,420
52-Week Range 13,740 - 23,700
Beta n/a
RSI 45.73
Earnings Date Aug 14, 2025

About ROKIT Healthcare

ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellul... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Employees 72
Stock Exchange KOSDAQ
Ticker Symbol 376900
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.